ViAqua Therapeutics

Oral Delivery Platform for Preventing Aquaculture Diseases

Startup

ViAqua Therapeutics is a Kadima Zoran-based startup in the Agriculture & Food Technologies sector, established in 2014. Oral Delivery Platform for Preventing Aquaculture Diseases. The company has raised a total of $16.05M across 5 funding rounds, currently at the Seed stage. ViAqua Therapeutics was founded by Shai Ufaz and Shai Einbinder. Key investors include S2G Investments, I-Lab Angels, Circle Investments, among 11 total investors. The company has 11-50 employees. Core technologies: Biologicals.

With $16.05M in total funding, ViAqua Therapeutics is a Seed-stage company operating in Agriculture & Food Technologies. The company follows a B2B business model. Product stage: R&D.

$16.05M
Raised
5
Rounds
11
Investors
3
Team
2014
Founded
Sector & Technology
Climate TechFood & Land UseSustainable FarmingHealth Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryAgriculture & Food TechnologiesAg TechFarm Equipment & TreatmentBiologicals
At a Glance
Investors

11 investors total

Founders
In the News

5 articles covered by sources including www.finsmes.com, www.prnewswire.com, www.businesstimes.com.sg, www.timesofisrael.com, www.calcalistech.com.

www.finsmes.com · Sep 5, 2023
ViAqua Therapeutics Raises $8.25M in Funding
Read article ↗
Frequently Asked Questions
What does ViAqua Therapeutics do?

ViAqua Therapeutics is the developer of an orally administered treatment designed to improve health management and prevent viral epidemics in aquaculture. The company's first product is designed for use in shrimp, which comprises 20% of the total international trade value of fish products. ViAqua's platform for health management in shellfish and fish utilizes a proprietary RNAi formulation that triggers the immune system and prevents viral infections. The coated particles are delivered via feed to produce the maximum effect and reduce cost.

How much funding has ViAqua Therapeutics raised?

ViAqua Therapeutics has raised $16.05M in total funding across 5 rounds. The company is currently at the Seed stage. Key investors include S2G Investments, I-Lab Angels, Circle Investments.

Who founded ViAqua Therapeutics?

ViAqua Therapeutics was founded in 2014 by Shai Ufaz (Co-founder & CEO), Shai Einbinder (Co-founder).

What sector is ViAqua Therapeutics in?

ViAqua Therapeutics operates in Climate Tech, Food & Land Use, Sustainable Farming, Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery, Agriculture & Food Technologies, Ag Tech, Farm Equipment & Treatment, with core technologies in Biologicals. Target customers: Agriculture & Food, Marine Life, Fish, Sea Food.

Where is ViAqua Therapeutics located?

ViAqua Therapeutics is based in Kadima Tzoran, Israel, Center District,North District.

View Full Profile Classic View Website ↗